Ritva Koskela - Concepedia

Author

Ritva Koskela

Oulu University Hospital ORCID

Also Known As

R Koskela, R. M. Koskela, RITVA KOSKELA, Ritva Koskela, Ritva M. Koskela, Ritva Maria Koskela, Roosa Koskela

Publications

582

Citations

H-Index

Concepts

All Affiliations

Oulu University Hospital University of Helsinki Helsinki University Hospital Tampere University Hospital Turku University Hospital

About

Ritva Koskela is an author at Oulu University Hospital.

Ritva Koskela

Publications

542

Citations

H-Index

Page 1

	Year	Citations
Achievement of deep remission during scheduled maintenance therapy with TNFα-blocking agents in IBD Pauliina Molander, Taina Sipponen, Helena Kemppainen, Journal of Crohn s and Colitis	2012	113
Does fecal calprotectin predict short-term relapse after stopping TNFα-blocking agents in inflammatory bowel disease patients in deep remission? Pauliina Molander, Martti Färkkilâ, Ari Ristimäki, Journal of Crohn s and Colitis	2014	94
Clinical characteristics of collagenous and lymphocytic colitis Ritva Koskela, Seppo Niemelä, Tuomo J. Karttunen, Scandinavian Journal of Gastroenterology	2004	79
Outcome After Discontinuation of TNFα-blocking Therapy in Patients with Inflammatory Bowel Disease in Deep Remission Pauliina Molander, Martti Färkkilâ, Kimmo Salminen, Inflammatory Bowel Diseases	2014	75
Human leucocyte antigen and TNFα polymorphism association in microscopic colitis Ritva Koskela, Tuomo J. Karttunen, Seppo Niemelä, European Journal of Gastroenterology & Hepatology	2008	61
Inflammatory Bowel Disease in Patients with Congenital Chloride Diarrhoea Lorenzo Norsa, Roberto Berni Canani, Rémi Duclaux‐Loras, Journal of Crohn s and Colitis	2021	24
Serological Biomarker Panel in Diagnosis of Atrophic Gastritis and<i>Helicobacter pylori</i>Infection in Gastroscopy Referral Patients: Clinical Validation of the New-Generation GastroPanel<sup>®</sup>Test Olli‐Pekka Koivurova, Ritva Koskela, Timo Blomster, Anticancer Research	2021	24
Cytokine gene polymorphism in microscopic colitis association with the IL-6-174 GG genotype Ritva Koskela, Tuomo J. Karttunen, Seppo Niemelä, European Journal of Gastroenterology & Hepatology	2011	20
Objectively assessed disease activity and drug persistence during ustekinumab treatment in a nationwide real-world Crohn’s disease cohort Clas-Göran af Björkesten, Tuire Ilus, Taru Hallinen, European Journal of Gastroenterology & Hepatology	2020	20
A nationwide real-world study on dynamic ustekinumab dosing and concomitant medication use among Crohn’s disease patients in Finland Taina Sipponen, Clas-Göran af Björkesten, Taru Hallinen, Scandinavian Journal of Gastroenterology	2021	20

Page 1